The effect of various cardenolides and bufadienolides with different cardiac activity on the 86-rubidium uptake of human erythrocytes.
D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects; D002018:Bufanolides / Q000494:pharmacology*; D002297:Cardanolides / Q000494:pharmacology*; D002301:Cardiac Glycosides / Q000633:toxicity; D002415:Cats; D004071:Digitalis Glycosides / Q000494:pharmacology; D004074:Digitoxin / Q000494:pharmacology; D004077:Digoxin / Q000494:pharmacology; D004912:Erythrocytes / Q000378:metabolism*; D006168:Guinea Pigs; D006801:Humans; D066298:In Vitro Techniques; D007928:Lethal Dose 50; D008297:Male; D010042:Ouabain / Q000494:pharmacology; D010946:Plants, Medicinal; D011868:Radioisotopes; D012413:Rubidium / Q000037:antagonists & inhibitors / Q000097:blood*; D013329:Structure-Activity Relationship
D002018:Bufanolides; D002297:Cardanolides; D002301:Cardiac Glycosides; D004071:Digitalis Glycosides; D011868:Radioisotopes; D010042:Ouabain; D004077:Digoxin; D004074:Digitoxin; D012413:Rubidium